Biotech stumbled in FY25, but we didn’t. HB Biotechnology kept its footing and delivered 23% outperformance in a tough market ...

Mantle trades between the 100-day and 200-day EMAs at $0.6869 and $0.7485, respectively, while holding dominance above the 23 ...

The Reserve Bank of Australia wants to scrap surcharge fees on card payments and cut other fees, in a move it thinks will ...